Clinical Trials Logo

Seropositive RA clinical trials

View clinical trials related to Seropositive RA.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03455842 Completed - Seropositive RA Clinical Trials

The BCD-089 (aIL6R) in Patients With Active Rheumatoid Arthritis

AURORA
Start date: February 1, 2018
Phase: Phase 2
Study type: Interventional

The study is Phase II randomized, double-blind, placebo-controlled clinical trial to evaluate efficacy and safety, pharmacokinetics and pharmacodynamics of 2 dosing regimens (qw and q2w, s/c) of monoclonal antibody to IL6R (BCD-089) in patients with active rheumatoid arthritis and inadequate response to methotrexate.